Enoxaparin API is a medicine active ingredient used as an anticoagulant medication with low molecular weight heparin. It is used to treat and prevent conditions like pulmonary embolism and deep vein thrombosis (DVT). This API is also used during pregnancy or in certain types of surgeries to avoid any complications. These are available in powder and injection types used in hospitals and clinics.This growth is primarily driven by Prevalence of Deep Vein Thrombosis and Pulmonary Embolism Related Health Problems and Rising Number of Surgery and Need for Preventing Any Complications.
Globally, a noticeable market trend is evident Increasing Consumption of Enoxaparin API Injection in the Treatment. Major Players, such as Rochem International (United States), Atabay (Turkey), Meitheal Pharmaceuticals (United States), Amphastar Pharmaceuticals (United States), Sanofi-Aventis (France), Venipharm (France), ROVI SA (Spain) and Hebei Changshan Biochemical Pharmaceutical Co. (China) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On 19th March 2019, Amphastar Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) granted approval of its Abbreviated New Drug Application (“ANDA”) for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial (MDV). The company currently manufactures and distributes Enoxaparin Sodium Injection in prefilled syringe form and this approval of the Multiple Dose Vial allows the company to begin offering the full line of Enoxaparin products.
On 28th May 2020, Meitheal Pharmaceuticals, Inc. announced the launch of Enoxaparin Sodium Injection, USP, the generic equivalent of Lovenox, in the United States market. Meitheal licenses Enoxaparin Sodium Injection exclusively through its partnership with Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (NKF), its majority shareholder.
- Prevalence of Deep Vein Thrombosis and Pulmonary Embolism Related Health Problems
- Rising Number of Surgery and Need for Preventing Any Complications
- Increasing Consumption of Enoxaparin API Injection in the Treatment
- Side Effect Related Risks with Enoxaparin API
Innovation and Advancement in the Pharmaceutical Industry and Surging Demand for Enoxaparin API from Developing Nations
Price Fluctuations in the Production of Enoxaparin API
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
AMA Research & Media features not only specific market forecasts, but also include significant value-added commentary on:
Technological Trends and Innovations
Regulatory Trends & Policies
Market Maturity Indicators
Market Share Movements
Growth Drivers and Constraints
New Entrants into the Market & Entry/Exit Barriers
Supporting Company Financial and Cash Flow Planning
Open Up New Markets
To Seize Powerful Market Opportunities
Key Decision in Planning and to Further Expand Market Share
Identify Key Business Segments, Market Proposition & Gap Analysis